相似文献
1
5(th) Asian PAD Workshop.
Ann Vasc Dis. 2014;7(2):199-218. doi: 10.3400/avd.pad.14.01000.
2
9 Asian PAD Workshop.
Ann Vasc Dis. 2018 Sep 25;11(3):427-436. doi: 10.3400/avd.pad.18-01000.
3
7(th) Asian PAD Workshop.
Ann Vasc Dis. 2016;9(2):135-47. doi: 10.3400/avd.pad.16-01000. Epub 2016 May 25.
4
8 Asian PAD Workshop.
Ann Vasc Dis. 2017 Dec 25;10(4):449-458. doi: 10.3400/avd.pad.17-01000.
5
6(th) Asian PAD Workshop.
Ann Vasc Dis. 2015;8(2):135-43. doi: 10.3400/avd.pad.15-00001.
6
Fourth Asian PAD Workshop.
Ann Vasc Dis. 2013;6(1):106-19. doi: 10.3400/avd.pad.12.01000.
7
Third Asian PAD Workshop.
Ann Vasc Dis. 2012;5(1):113-29. doi: 10.3400/avd.pad.12.00125.
8
First Asian PAD workshop.
Ann Vasc Dis. 2010;3(1):87-102. doi: 10.3400/avd.AVDpad09001. Epub 2010 Jul 21.
9
Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis.
Diabetes Res Clin Pract. 2007 Apr;76(1):82-92. doi: 10.1016/j.diabres.2006.07.029. Epub 2006 Sep 6.
10
Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians.
BMC Med. 2022 Aug 31;20(1):300. doi: 10.1186/s12916-022-02476-0.
引用本文的文献
1
Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection.
Med Devices (Auckl). 2016 Oct 13;9:349-360. doi: 10.2147/MDER.S98889. eCollection 2016.
本文引用的文献
1
Chapter 1: Definition and classification of CKD.
Kidney Int Suppl (2011). 2013 Jan;3(1):19-62. doi: 10.1038/kisup.2012.64.
2
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
3
Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy.
Nephrol Dial Transplant. 2013 Aug;28(8):2116-22. doi: 10.1093/ndt/gft103. Epub 2013 May 31.
4
Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.
Ther Apher Dial. 2013 Apr;17(2):185-92. doi: 10.1111/j.1744-9987.2012.01149.x. Epub 2012 Dec 7.
5
Double filtration plasmapheresis in different diseases in Thailand.
Ther Apher Dial. 2013 Feb;17(1):99-116. doi: 10.1111/j.1744-9987.2012.01105.x. Epub 2012 Nov 15.
6
Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.
Ther Apher Dial. 2012 Oct;16(5):387-435. doi: 10.1111/j.1744-9987.2012.01088.x.
7
Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation.
BMC Neurol. 2012 Sep 24;12:102. doi: 10.1186/1471-2377-12-102.
8
Fibroblast growth factor 23 and Inflammation in CKD.
Clin J Am Soc Nephrol. 2012 Jul;7(7):1155-62. doi: 10.2215/CJN.13281211. Epub 2012 May 3.
9
Therapeutic apheresis in peripheral and retinal circulatory disorders.
Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):41-4. doi: 10.1007/s11789-012-0045-7.
10
Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice.
J Endocrinol. 2012 Jun;213(3):285-91. doi: 10.1530/JOE-12-0014. Epub 2012 Mar 29.
Zotero 插件